Literature DB >> 7981958

Vascular interactions of lipoprotein (a).

A C Liu1, R M Lawn.   

Abstract

Lipoprotein (a) is a major inherited risk factor for vascular diseases, including coronary atherosclerosis, restenosis, and stroke. The pathologic mechanisms are uncertain, but are likely to involve the unique plasminogen-like component of this lipoprotein, apolipoprotein (a). Studies suggest that apolipoprotein (a) can enhance lipid deposition in vessel walls, interfere with fibrinolysis, modulate smooth muscle cell activity, and induce endothelial dysfunction. This review discusses the key concepts relating to these mechanisms, with emphasis on recent studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7981958     DOI: 10.1097/00041433-199408000-00005

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  5 in total

1.  Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix.

Authors:  S Pillarisetti; L Paka; J C Obunike; L Berglund; I J Goldberg
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

Review 2.  New approaches to the prevention of atherosclerosis.

Authors:  M Naito; T Hayashi; A Iguchi
Journal:  Drugs       Date:  1995-09       Impact factor: 9.546

3.  Evaluation of a new apolipoprotein(a) isoform-independent assay for serum Lipoprotein(a).

Authors:  T Dembinski; P Nixon; G Shen; D Mymin; P C Choy
Journal:  Mol Cell Biochem       Date:  2000-04       Impact factor: 3.396

Review 4.  Plasmin activation system in restenosis: role in pathogenesis and clinical prediction?

Authors:  G Christ; K Kostner; M Zehetgruber; B R Binder; D Gulba; K Huber
Journal:  J Thromb Thrombolysis       Date:  1999-06       Impact factor: 2.300

5.  Kringle-containing fragments of apolipoprotein(a) circulate in human plasma and are excreted into the urine.

Authors:  V Mooser; S M Marcovina; A L White; H H Hobbs
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.